The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...

People who visit emergency departments because of hallucinogenic drug use are at a heightened risk of developing ...

New research highlights neuroglia (or glia cells) as critical players in mental health, potentially influencing conditions like depression and schizophrenia.

For patients with schizophrenia, repetitive transcranial magnetic stimulation (rTMS) was effective and safe in treating ...

AbbVie reports disappointing mid-stage data for its schizophrenia drug. Jason Snipe of Odyssey Capital still likes AbbVie ...

AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...

Researchers have developed a potential diagnostic tool for schizophrenia by observing how patients process conflicting information.

Since then, our work, as well as that of other teams, has shown that social cognition impairments mediate the relationship ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. The results underscore the ...

Early detection of schizophrenia can make a huge difference. Recognising the signs and symptoms before they fully develop can lead to earlier interventions, helping to reduce the severity of the ...

Some customers have been left bewildered at a venue that contains a total of 21 signs across its grounds, according to reporting from news agency SWNS. The notices at Hidden Gem Café in ...

the signs of the disturbance may be manifested by only negative symptoms or by two or more symptoms listed in Criterion A present in an attenuated form (e.g., odd beliefs, unusual perceptual ...